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RESEARCH ARTICLE Open Access
Whole genome sequencing identified a 16
kilobase deletion on ECA13 associated with
distichiasis in Friesian horses
E. A. Hisey1, H. Hermans2, Z. T. Lounsberry1, F. Avila1, R. A. Grahn1, K. E. Knickelbein1,3, S. A. Duward-Akhurst4,
M. E. McCue4, T.S. Kalbfleisch5, M. E. Lassaline6, W. Back2,7 and R. R. Bellone1,8*
Abstract
Background: Distichiasis, an ocular disorder in which aberrant cilia (eyelashes) grow from the opening of the
Meibomian glands of the eyelid, has been reported in Friesian horses. These misplaced cilia can cause discomfort,
chronic keratitis, and corneal ulceration, potentially impacting vision due to corneal fibrosis, or, if secondary
infection occurs, may lead to loss of the eye. Friesian horses represent the vast majority of reported cases of equine
distichiasis, and as the breed is known to be affected with inherited monogenic disorders, this condition was
hypothesized to be a simply inherited Mendelian trait.
Results: A genome wide association study (GWAS) was performed using the Axiom 670 k Equine Genotyping array
(MNEc670k) utilizing 14 cases and 38 controls phenotyped for distichiasis. An additive single locus mixed linear
model (EMMAX) approach identified a 1.83 Mb locus on ECA5 and a 1.34 Mb locus on ECA13 that reached
genome-wide significance (pcorrected = 0.016 and 0.032, respectively). Only the locus on ECA13 withstood replication
testing (p = 1.6 × 10− 5, cases: n = 5 and controls: n = 37). A 371 kb run of homozygosity (ROH) on ECA13 was found
in 13 of the 14 cases, providing evidence for a recessive mode of inheritance. Haplotype analysis (hapQTL)
narrowed the region of association on ECA13 to 163 kb. Whole-genome sequencing data from 3 cases and 2
controls identified a 16 kb deletion within the ECA13 associated haplotype (ECA13:g.178714_195130del). Functional
annotation data supports a tissue-specific regulatory role of this locus. This deletion was associated with distichiasis,
as 18 of the 19 cases were homozygous (p = 4.8 × 10− 13). Genotyping the deletion in 955 horses from 54 different
breeds identified the deletion in only 11 non-Friesians, all of which were carriers, suggesting that this could be
causal for this Friesian disorder.
Conclusions: This study identified a 16 kb deletion on ECA13 in an intergenic region that was associated with
distichiasis in Friesian horses. Further functional analysis in relevant tissues from cases and controls will help to
clarify the precise role of this deletion in normal and abnormal eyelash development and investigate the hypothesis
of incomplete penetrance.
Keywords: Genome wide association study (GWAS), Distichiasis, Meibomian gland, Haplotype, Whole genome
sequencing (WGS), Functional annotation of animal genomes (FAANG), Histone marks, Eyelash
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Background
Eyelashes serve to protect the eye from airborne parti-
cles and to prevent other debris from entering the eye.
During embryonic development, the epidermal cells
interact with the mesenchyme to form hair follicles, all
of which are present at birth, with no additional follicles
forming later in life [1, 2]. Like other body hairs, the
growth of eyelashes follows a cyclical pattern. The
growth cycle of the eyelash in humans is noted to be
longer than body hairs, taking approximately 5 months
to complete [3]. It has also been found that eyelashes
have a shorter anagen phase and a longer telogen phase
than other body hairs, contributing to the shorter length
of the eyelashes [3].
Meibomian glands are holocrine glands present along
the eyelid margin and are closely associated with the lash
follicle, though eyelashes typically exit the skin anterior
to the Meibomian gland orifice [4]. Meibomian glands
are considered modified sebaceous glands because of the
unique combination of lipids they secrete to assist in the
prevention of evaporation of the tear film [5, 6].
Distichiasis is a condition in which eyelashes exit
through the Meibomian gland orifice [5, 7]. In cases of
distichiasis, it is hypothesized that the Meibomian glands
have regained an ancestral hair-bearing function, and
thus, a lash grows from the opening [5, 8]. Another hy-
pothesis is that a primary epithelial germ cell fails to dif-
ferentiate into a sebaceous gland and instead becomes a
complete pilosebaceous unit, which is associated with a
hair [9]. Meibomian glands affected with distichiae are
structurally abnormal based on meibography [6]. While
distichiae can be shorter, thinner and less pigmented
than normal eyelashes [8], they can also be thick and
stiff and thus capable of causing tearing, corneal irrita-
tion, keratitis, and corneal erosions or ulcers, which can
impact ocular comfort and vision, and may lead to sec-
ondary infection [5, 10–12].
Two novel dominant mutations in forkhead box pro-
tein C2 (FOXC2) have been associated with distichiasis
in humans [13, 14]. FOXC2 is a transcription factor that
plays a major role during embryogenesis [14] although
the precise regulatory function of this gene is not well
understood. Both mutations are nonsense mutations,
truncating the protein and impairing DNA-binding,
which in turn prevents it from acting as a transcription
factor. The complete list of genes regulated by FOXC2 is
not known and these mutations only explain the disease
in two families suggesting that other unexplained genetic
mechanisms for distichiasis in humans may exist. Con-
genital distichiasis is also commonly seen in dogs. The
mode of inheritance in this species is reported to be
dominant with incomplete penetrance [15]. Despite its
occurrence in multiple dog breeds, a genetic mechanism
has not been identified for this disorder.
In the two published reports of distichiasis in horses, 19
of the 20 cases were of the Friesian breed (Fig. 1) [11, 12].
Utter and Wotman [11] describe distichiasis causing re-
current corneal ulceration in two Friesian horses located
in the United States. In a retrospective analysis, Hermans
and Ensink [12] reported a high rate of recurrence despite
treatment, particularly when individuals had five or more
aberrant lashes, and that all cases presented with irritation
or ulceration [12]. The number of Friesian cases presented
in these two reports suggests a genetic basis for distichiasis
in this breed.
Friesians have been shown to have a high degree of in-
breeding [16]. Inbreeding is thought to be responsible
for a number of suspected genetic disorders identified in
this breed, including hydrocephalus, dwarfism, bilateral
corneal stromal loss (BCSL), megaesophagus, retained
placenta, aortic rupture, and chronic progressive lymph-
edema [17–24]. Recessive causal mutations have been
identified for two of those disorders: hydrocephalus
(B3GALNT2c.1423C > T) and dwarfism (B4GALT7c.50G >
A) [17, 18]. As Friesians have been documented to have
recessive Mendelian disorders, have a high level of in-
breeding, and the incidence of distichiasis seems higher
than in other breeds, it was hypothesized that in Friesian
horses distichiasis is a recessively inherited disorder. To
investigate this hypothesis, a genome wide association
study (GWAS) was performed to identify candidate loci
followed by whole genome sequencing (WGS) and func-




A pedigree analysis identified that 30% of cases traced
back to a single common ancestor (GS3, Fig. 2) within
two generations, providing support of a genetic predis-
position for distichiasis. Specifically, five of the 21 cases
were identified as half-siblings (offspring of S3, Fig. 2)
and two additional cases traced back to his sire (GS3).
The total inbreeding coefficients were calculated and
compared between cases (Mdn = 0.144) and controls
(Mdn = 0.147), with no statistically significant difference
detected (p = 0.31 and U = 425). However, the inbreeding
coefficient for all horses in this analysis was high at
14.1%.
Genome wide association study
A chi-squared basic allelic association identified a 1.83
Mb locus on ECA5 and a 1.34Mb locus on ECA13 that
reached genome-wide significance (Fig. 3a). Two signifi-
cant SNPs (pcorrected = 0.025) were found5s on the ECA5
locus, while the locus on ECA13 contained 16 significant
SNPs (pcorrected < 0.042). However, the genomic inflation
in this analysis was high (λ = 1.50). To correct for the
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unequal relatedness in the GWAS cohorts, an EMMAX
analysis was performed. Under an additive model, the
loci on ECA5 and ECA13 were further supported (pcor-
rected = 0.016 and pcorrected = 0.031, respectively; λ = 1.03,
Fig. 3b).
Haplotype analysis of the ECA13 associated locus identi-
fied a 371 kb run of homozygosity (ROH) in 13 out of 14
cases, which was significantly associated with disease (chi-
squared p = 3.9 × 10− 9, Table 1). This haplotype contained
three genes: FAM20C, PRKAR1B, and PDGFA.
hapQTL
Three significant ancestral haplotypes were also identi-
fied based on their Bayes Factor (BF) values of less than
0.0001 [25]: the same loci on ECA5 and ECA13, plus a
locus on ECA12 (Fig. 4). This narrowed the candidate
region on ECA5 to 235 kb and to 163 kb on ECA13. The
locus on ECA12 contains one small haplotype spanning
375 bp, which encompassed only two SNPs.
Replicating GWAS associations
To confirm genotyping results and replicate associations,
SNPs that reached genome-wide significance in the
GWAS (27 SNPs from ECA5 and ECA13) or haplotype
analyses (2 SNPs from ECA12) were genotyped in all
horses from the GWAS plus a replication sample set in-
cluding five additional cases and 37 additional controls.
In the replication sample set, the loci on ECA5 and
ECA12 no longer reached significance (p > 0.40, Table 2).
However, the ECA13 locus was further supported as it
continued to reach genome wide significance in the
Fig. 1 Distichiasis in a Friesian horse. a Normal eyelashes developing from the outer surface of the lid. b Aberrant eyelashes growing from the
Meibomian gland orifices of the inferior eyelid margin. Note the eyelashes growing such that they are in direct contact with the cornea
Fig. 2 Distichiasis Pedigree Investigation. Represented is the most informative portion of the pedigree. Specifically, pedigree analysis showed that
five of 21 affected horses shared a common ancestor within a single generation (S3, indicated with an orange border), which was not related to
any of the controls. Two additional affected horses could be traced to the sire of S3 (GS3, indicated with a yellow border). Taken together, these
findings support a genetic basis for this disease. Cases are denoted with red shading. Disease states of ancestors are unknown and denoted with
white shading. One unaffected individual is denoted with blue shading
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replication sample set (p = 1.6 × 10− 5 and combined data
set: p = 5.1 × 10− 14, Table 2).
Genotyping the associated SNPs from the GWAS ana-
lyses was completed through a MassARRAY assay or a
PCR-RFLP assay. To test for significance, a Fisher’s exact
test for basic allelic associations was performed. Data from
the original GWAS sample set (n = 14 case and n = 38
controls), the replication sample set (n = 5 cases and n =
37 controls), and the combined data set are presented.
Whole genome sequencing
While FOXC2 (ECA3) did not fall within a region of asso-
ciation in this GWAS, variants in this gene have been
associated with distichiasis in humans [13, 14], thus it was
investigated as a candidate gene for equine distichiasis.
Analysis of WGS data from the coding region of this gene
identified four variants (three intronic and one synonym-
ous variant: ECA3:g.34103404C > T; rs1145785150), but
none of these were concordant with phenotype in the
three cases sequenced and therefore they were not investi-
gated further.
Replication testing supported further investigation of
the ECA13 locus, coding variants in the WGS data for
the three ECA13 positional candidate genes, FAM20C,
PRKAR1B and PDGFA, were investigated. No variants
concordant with phenotype were identified in the three
cases and two controls sequenced. However, 32 variants
from the associated haplotype were prioritized for fur-
ther analysis. These variants were either perfectly con-
cordant with the phenotype in the WGS sample set (n =
3 cases and n = 2 controls) or were predicted by SnpEff
to impact protein function (Table S1). These 32 variants
were genotyped via Agena MassARRAY spectrometry in
the cohort of Friesian horses. Five of these variants,
Fig. 3 Manhattan Plots from GWAS Analyses. Plots are organized by chromosome (denoted by different colors). The modified Bonferroni
correction threshold is indicated by the black line (−log10(p) = 6.08). a –log10(p-values) from a chi-squared analysis for basic allelic association
(λ = 1.5) (b) –log10(p-values) from a single locus mixed linear model (EMMAX) analysis under an additive model (λ = 1.0). b Two loci reach
genome wide significance, on ECA5 and ECA13 after correcting for genomic inflation (pcorrected = 0.016 and 0.032, respectively)





Cases 14 13 1 0
Controls 38 4 17 17
A significant ROH was identified in the ECA13 associated locus (chi-squared
test for independence, p = 3.9 × 10− 9)
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which were predicted to be synonymous or modifier (in-
tronic) variants, failed to genotype. Twenty variants
failed to pass quality control (minor allele frequency <
0.05), indicating that these were not polymorphic in our
sample set and thus were not segregating with disease
status. The remaining seven variants were evaluated fur-
ther (Table 3).
Visual inspection of the WGS data from the associated
ECA13 locus identified a deletion in this region. Specif-
ically, the binary alignment files (BAM) were inspected
using the Integrative Genomics Viewer (IGV). No cover-
age in a 16.42 kb region in this locus was detected in the
cases; coverage was consistent across the two controls in
this region with roughly half the number of reads as the
flanking sequences, suggesting the two controls were
heterozygous for this deletion (Fig. 5). This variant was
later confirmed as the only structural variant in the
ECA13 associated haplotype using LUMPY.
Sanger sequencing of the deletion in two cases and
two controls identified the boundaries to occur at
ECA13:g.178714_195130del. Further genotyping of the
deletion using an allele specific PCR assay in our entire
phenotyped sample (n = 94) determined that the deletion
was significantly associated with phenotype as all but
one case was homozygous for this structural variant
(chi-squared p = 4.8 × 10− 13, Table 4). However, seven
out of 75 controls were also homozygous for this variant.
A random sample set of Friesian horses that were not
phenotyped (n = 201, banked in the Bellone laboratory)
were evaluated and the allele frequency was estimated to
be 0.32 (Table 4). Due to the moderate allele frequency,
the frequency for the two other reported recessive
mutations in the Friesian breed was also assessed in a
non-phenotyped subset of the sample (n = 73). Based on
these data, the estimated allele frequencies were deter-
mined to be 0.075 for hydrocephalus and 0.062 for
dwarfism. None of the other prioritized WGS variants in
the associated locus on ECA13 were found to be as con-
cordant with phenotype as the 16 kb deletion (Table 3).
To determine if this deletion occurs in other breeds,
955 horse samples from 54 breeds were genotyped.
These included 279 samples banked in the Bellone la-
boratory (Haflingers: n = 51, Belgian Draft horses: n = 47,
Thoroughbreds: n = 95, Quarter Horses: n = 86), 287
horses for which WGS data were publicly available, and
WGS data contributed by the McCue laboratory (n =
389). The deletion was only identified in 11 non-Friesian
individuals in the heterozygous state (1.15%) (Table 5).
Functional investigation
As this locus on ECA13 contains no annotated protein-
coding genes and no functional data currently exists for
eyelid tissue or Meibomian glands, the equine data col-
lected for the Functional Annotation of Animal Ge-
nomes (FAANG) project, including RNA-seq [26, 27]
and ChIP-seq data [28] from two clinically healthy Thor-
oughbred mares, were evaluated to develop additional
hypotheses on the functional mechanisms of this variant.
To investigate if there was tissue-specific variation in
gene expression in clinically normal horses, the three
genes near the deletion (FAM20C, PRKAR1B and
PDGFA) were assessed in the RNA-seq data. The three
genes were expressed in all eight tissues (adipose, brain,
heart, lamina, liver, lung, ovary, muscle), which did not
Fig. 4 Haplotype Analysis. BF2 values from a genome-wide haplotype-based analysis using hapQTL. A significance threshold of log10(BF2) > 4 was
utilized [25]. Haplotypes on ECA5, ECA12 and ECA13 were found to be significant, further supporting and narrowing the regions of association on
ECA5 and ECA13 from the initial GWAS
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help to further elucidate the putative impact of the dele-
tion on gene function. However, in assessing the deletion
in the publicly available equine ChIP-Seq data, tissue-
specific histone modifications were identified in seven of
the eight tissues for which data are available (Fig. 6)
[29]. The only tissue with no detected peaks, or genomic
locations with significant enrichment for histone interac-
tions, was lung. Interestingly, lamina has evidence of an
active enhancer at this locus, with tissue-specific peaks
identified for H3K4me1 and H3K27ac [29]; conversely,
heart and ovary show evidence of repression in this re-
gion indicated by H3K27me3 peaks along with
H3K4me1and H3K27ac peaks (Fig. 6) [29]. These find-
ings indicate that there are tissue-specific differences in
Table 2 GWAS Replication Testing
Name Original sample p-value Replication sample p-value Combined p-value
ECA13:g.340918C > T 2.26 × 10−8 1.61 × 10−5 5.71 × 10− 14
ECA13:g.343850A > C 2.26 × 10− 8 1.61 × 10− 5 5.71 × 10− 14
ECA13:g.330462G > A 2.73 × 10− 7 2.34 × 10− 5 8.58 × 10− 13
ECA13:g.425443C > T 4.16 × 10− 7 1.45 × 10− 4 1.64 × 10− 11
ECA13:g.230097C > T 2.27 × 10− 7 2.30 × 10− 4 2.31 × 10− 11
ECA13:g.134040A > G 8.15 × 10− 8 3.07 × 10− 4 2.31 × 10− 11
ECA13:g.142416C > T 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.153435C > T 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.195278 T > C 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.198581G > C 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.200759 T > C 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.201534G > A 2.27 × 10− 7 3.07 × 10− 4 2.73 × 10− 11
ECA13:g.206996G > A 2.27 × 10− 7 4.06 × 10− 4 3.75 × 10− 11
ECA13:g.121325G > A 2.73 × 10− 7 1.07 × 10− 3 1.12 × 10− 11
ECA13:g.122064G > A 2.73 × 10− 7 1.07 × 10− 3 1.12 × 10− 11
ECA13:g.122243C > T 2.73 × 10− 7 1.07 × 10− 3 1.12 × 10− 11
ECA13:g.316346C > T 2.73 × 10− 7 1.07 × 10− 3 1.12 × 10− 11
ECA13:g.13611A > G 7.73 × 10− 7 1.10 × 10− 3 3.94 × 10− 10
ECA13:g.42897A > G 2.73 × 10− 7 1.10 × 10− 3 1.45 × 10− 10
ECA13:g.32112G > T 8.48 × 10− 7 1.39 × 10− 3 1.36 × 10− 9
ECA13:g.384663 T > C 5.94 × 10− 6 2.00 × 10− 3 5.77 × 10− 9
ECA13:g.15928A > G 8.15 × 10− 8 0.0288 2.04 × 10− 9
ECA5:g.39962594G > A 4.57 × 10− 6 0.404 4.65 × 10− 9
ECA5:g.39863319A > Ga 4.57 × 10− 6 0.478 1.28 × 10− 5
ECA12:g.3271275C > A 9.10 × 10− 6 0.716 6.75 × 10− 4
ECA12:g.3270900 T > C 1.57 × 10− 5 1 4.65 × 10− 4
ECA13:g.186975G > Ab 1 1 1
ECA13:g.189306C > Tb 1 1 1
ECA13:g.190216 T > Cb 1 1 1
a This SNP was assessed through a PCR-RFLP analysis
bAs these SNPs fall within the 16 kb deletion, they only yielded results in one case (see Fig. 5)
Table 3 Association Testing of Prioritized Variants Identified by
Whole Genome Sequencing from the ECA13 Locus
Name p-value
ECA13:g.178,714–195,130dela 1.90 × 10− 15
ECA13:g.117852G > A 2.31 × 10− 11
ECA13:g.127995G > A 2.31 × 10− 11
ECA13:g.134862C > G 2.31 × 10− 11
ECA13:g.138340G > A 2.74 × 10−11
ECA13:g.125711 T > C 1.12 × 10−10
ECA13:g.158596G > A 1.45 × 10−8
ECA13:g.710940 T > C 1
aThis variant was genotyped by an allele specific PCR assay
Results of Fisher’s exact tests for basic allelic associations are presented.
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histone modifications at this locus that could be im-
pacted by the deletion.
Discussion
A pedigree analysis of Friesian horses affected with disti-
chiasis identified an average inbreeding coefficient of
14.1% in the cohort under investigation, which is higher
than that reported for other breeds with closed stud-
books (Thoroughbreds = 12.5% and Standardbreds =
8.88%) [30, 31]. In support of this, Schurink et al. 2019
[16] found that the Friesian horse was the most inbred
and had the smallest effective population size of the nine
breeds they studied based on an analysis of the inbreed-
ing coefficients, the length of ROHs, and measures of
linkage disequilibrium. They reported an even higher
average inbreeding coefficient 25.5% in the Friesian
population they investigated [16]. This high level of
inbreeding may explain why Friesians have several re-
ported recessive genetic disorders and supports investigat-
ing distichiasis as a recessive trait [17–24].
GWAS and haplotype analyses identified three poten-
tial regions of interest (ECA5, ECA12 and ECA13) asso-
ciated with distichiasis, and additional testing further
supported the region on ECA13 (p = 1.6 × 10− 5). Given
that the associations on ECA5 and ECA12 could not be
replicated, we concluded these associations were false
positives and therefore did not investigate them further.
Interrogation of the associated ECA13 locus using high
throughput short-read WGS data did not identify any
variants within the coding sequence of the three pos-
itional candidate genes. SnpEff identified 32 variants
from the associated haplotype, but none were perfectly
concordant with the phenotype. The identified 16 kb de-
letion (ECA13:g.178714_195130del) was also not
Fig. 5 Visualization of Whole Genome Sequencing Data Identifies 16.42 kb Deletion. BAM files were visually inspected using the Integrative
Genomics Viewer (IGV). No reads were detected in three cases within a 16.42 kb region (ECA13:g.178,714–195,130del), but were found in the
controls at approximately half the coverage of the flanking sequence
Table 4 Validation of ECA13 16 kb Deletion in Sample of
Friesian Horses
n Del/Del Ref/Del Ref/Ref
Cases 19 18 1 0
Controls 75 7 30 38
Unknown phenotype 201 21 88 92
Del refers to the ECA13 16 kb deletion and Ref signifies detection of the
reference allele.
Genotyping for the deletion was completed through an allele specific PCR
assay in the phenotyped cohort (n = 94) and in an additional sample set of
horses that were not phenotyped for disease, which estimated the allele
frequency to be 32.34%.
Table 5 Number of Horses from Additional Breeds Identified
with the 16 kb Deletion on ECA13 Based on Evaluation of 955
Samples
Breed Horses
Native Mongolian Chakouyi Horse 1
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perfectly concordant with disease but was the most con-
cordant with disease phenotype (cases: n = 19 and con-
trols: n = 75, p = 4.8 × 10− 13).
Eighteen out of 19 cases were homozygous for the 16
kb deletion; however, seven out of 75 controls were also
homozygous for the deletion. While the controls on
Fig. 6 Visualization of Histone Mark Functional Annotation Data in the ECA13 Deletion. BED files of ChIP-Seq histone marks (H3K4me1, H3K4me3,
H3K27ac, and H3K27me3) were visually assessed using the Integrative Genomics Viewer (IGV). The diversity of histone marks among these tissues
supports the presence of tissue-specific regulatory elements in the ECA13 deletion. Active marks are represented in varying shades of blue and
repressive marks are shown in orange
Hisey et al. BMC Genomics          (2020) 21:848 Page 8 of 13
average were older than the cases in this study (average
age of cases was 8.2 while that of the controls was 12.4
years), how age impacts disease is unknown. It is pos-
sible that these seven controls may develop aberrant
lashes at some point later in life. It is equally possible
that aberrant lashes were in the telogen phase of the hair
cycle and thus were not detectable when these seven
controls were examined on a single occasion. Reexami-
nation of these seven controls was attempted, but was
not possible as the horses were either deceased or not
accessible. Alternatively, it is possible that this mutation
is incompletely penetrant. This is suspected to be the
case for inherited distichiasis in dogs [15]. Horses homo-
zygous for the deletion but not showing signs of disease
may have protective genetic variants and/or some envir-
onmental trigger maybe impacting disease status. Per-
forming a longitudinal study, with multiple ocular
examinations over time to evaluate different phases of
the hair cycle in horses genotyped for the ECA13:
g.178714_195130del deletion will help to further evalu-
ate the plausibility of incomplete penetrance. Addition-
ally, performing ocular exams and genotyping for the
ECA13 deletion on sires and dams of the horses homo-
zygous for the deletion should aid in segregation analysis
needed to further evaluate the recessive mode of inherit-
ance proposed and enable a precise estimate of
penetrance.
A single horse with distichia was not homozygous
for the ROH identified as a part of the GWAS ana-
lysis and was heterozygous for the deletion. This case
had an atypical presentation relative to the other
cases, with only a single unilateral aberrant lash, while
the other cases had multiple lashes and/or obvious
corneal lesions. This horse was also not available for
reexamination.
The estimated allele frequency of ECA13:g.178714_
195130del (32.3%) is higher than the allele frequency
identified in a subset of this sample for the other reces-
sive conditions reported in this breed (7.5 and 6.2% for
hydrocephalus and dwarfism, respectively). This could
be because hydrocephalus has fatal consequences and
because dwarfism is readily identified and selected
against. Additionally, both hydrocephalus and dwarfism
are present at birth, thus these cases are identified prior
to breeding. While distichiasis can be a significant
source of discomfort and a vision-threatening problem
in some individuals, some cases may not have obvious
clinical signs. Therefore, horses with distichiasis may be
bred if they are asymptomatic, have mild clinical signs,
or if they have not yet developed the disease, thus propa-
gating the disorder in the Friesian population. It is also
possible that this deletion impacts regulation of a gene
associated with a favorable phenotype in the breed, and
thus is undergoing positive selection.
A study by Conant et al. 2011 [32] reported that Friesians
and Haflingers are more closely related than other Iberian
breeds, and Schurink et al. 2019 [16] determined that
Belgian Draft horses are also closely related to Friesians.
Therefore, a sample of phenotyped Haflingers and Belgian
Draft horses were evaluated to detect the presence and fre-
quency of this mutation as neither of these closely related
breeds are reported to have distichiasis. Quarter Horses
and Thoroughbreds were also investigated as more dis-
tantly related breeds. The deletion was not detected in any
of the 279 horses from these four breeds. However, in
evaluating 287 genomes available in the Sequence Read
Archive (SRA) and an additional 389 provided by the
McCue laboratory comprising of 54 breeds, only 11 horses
of diverse breeds not shown to be related to the Friesian
breed were identified to have the deletion (Table 5). This
suggests that the deletion is not a Friesian-specific muta-
tion, but rather an old mutation that predates the formation
of the Friesian breed. Evaluating the frequency of this muta-
tion and its presence in horses that have undergone ocular
phenotyping is warranted in the other breeds in which the
mutation was identified.
According to the EquCab3.0 reference genome [26],
the identified deletion lies in the intergenic region be-
tween FAM20C and PDGFA, which are both included in
the associated haplotype identified on ECA13. Because
of this, these two genes and the next closest gene, PRAK
R1B, were considered as positional candidates. Based on
known function, PDGFA was considered most likely to
be involved in distichiasis. The PDGF family acts as a
paracrine growth factor that mediates epithelial-
mesenchymal interactions in various tissue types. As
such, PDGFA has been shown to play a role in the for-
mation of submandibular salivary glands in mice [33]. In
cell culture of submandibular salivary glands, increased
levels of PDGFA caused an increase in branching and
epithelial proliferation [33]. More work is needed to elu-
cidate if PDGFA is expressed in normal Meibomian
glands and if there is differential expression in distichia-
affected glands that leads to the expression of a hair
bearing function.
Analysis of the equine FAANG RNA-seq data from
two normal horses showed no tissue-specific variation in
gene expression for FAM20C, PDGFA, and PRKAR1B,
and thus did not provide any insight into potential puta-
tive impact of the deletion on gene function. However,
putative regulatory elements were identified that could
play a role in distichiasis. This study represents the first
utilization of the FAANG histone ChIP-seq data to de-
velop hypotheses related to regulatory regions of the
genome and illustrates the importance of these datasets
as a reference for future investigations. The presence of
an active enhancer at this locus, as indicated by
H3K4me1 and H3K27ac in lamina, along with evidence
Hisey et al. BMC Genomics          (2020) 21:848 Page 9 of 13
of repression in five other tissues with H3K27me3 marks
in the deleted region, support this site as a tissue-
specific regulatory region. Of the tissues assessed, lamina
is the most similar to the ocular lid margin as both tis-
sues have an extensive extracellular matrix. The pres-
ence of an active enhancer in lamina suggests that these
regulatory elements could be important to Meibomian
gland function. We, therefore, hypothesize that an enhan-
cer located in the deleted region plays a role in regulating
the expression of PDGFA and that deletion of this enhan-
cer site could modify gene expression. In turn, it might
cause the Meibomian glands to form a hair-bearing struc-
ture as opposed to its normal secretory function, leading
to distichiasis. To test these hypotheses, eyelid tissue, in-
cluding the Meibomian glands, from affected and un-
affected horses needs to be investigated using RNA-seq
and other functional annotation methods.
The discovery of a novel variant associated with disti-
chiasis will enable genetic testing allowing for marker
assisted selection, which provides the opportunity to
lower the incidence of the disorder in the Friesian popu-
lation. It will also help in the identification of horses
likely to be affected by distichiasis, thus allowing horse
owners to screen horses for the disorder and potentially
provide intervention prior to the development of clinical
signs and irreversible corneal damage leading to better
welfare for these horses.
Conclusions
This study successfully identified genomic regions asso-
ciated with distichiasis, and further analysis identified a
16 kb deletion (ECA13:g.178714_195130del) that was as-
sociated with the disease phenotype. Given its associ-
ation and its location in relation to poised and active
enhancers, this variant warrants further investigation as
causal for distichiasis. Further exploration of the func-
tional consequences of this deletion may help to explain
the underlying etiology of distichiasis and penetrance in
Friesian horses, humans, dogs and other species.
Methods
Samples and DNA extraction
Ninety-nine privately owned, registered Friesian horses
were phenotyped for inclusion in this study and
remained in their owners’ care for the duration of the
study. A complete ocular examination of the adnexa (ad-
joining surfaces), anterior and posterior segments of
both eyes was performed by a diplomate of the European
or American College of Veterinary Ophthalmologists.
Horses with clinical signs consistent with disease, or
with a history of aberrant cilia, were included as cases
(n = 24, ages from 2 to 16, Fig. 1b). DNA was not avail-
able from five of these cases. Unaffected horses had no
medical history of aberrant cilia and no aberrant cilia
detected on examination (n = 75, ages from 1 to 24, Fig.
1a). In the replication sample set, horses with other ocu-
lar pathologies were excluded as additional controls.
Whole blood and/or mane or tail hair with follicles were
collected and genomic DNA was extracted as described
in Bellone et al. 2017 [34].
Pedigree analysis
To investigate possible modes of inheritance for disti-
chiasis, a pedigree analysis was conducted using 8-
generation pedigrees from 21 cases and 48 controls.
Pedigree information was obtained from the Royal Frie-
sian Horse Studbook (Koninklijke Friesch Paarden Stam-
boek:KFPS) database [35]. Pedigrees were compiled,
visualized and analyzed using Pedigraph [36]. Inbreeding
coefficients were calculated for cases and controls and
compared using a Mann-Whitney U test [37].
Genome wide association study
A genome wide association study of 14 cases and 38
controls was performed to identify loci of interest for
distichiasis. Genotyping was performed by GeneSeek
(Neogen Genomics, Lincoln, NE) using the Axiom 670 k
Equine Genotyping array [38]. Analysis and visualization
were performed using the Golden Helix SNP and Vari-
ation Suite (SVS) [39]. Prior to analysis, the data were
remapped to the EquCab3.0 reference genome, reducing
the number of SNPs from 670,796 to 636,999 SNPs [40].
Quality control consisted of the exclusion of samples
with call rates ≤0.95 and SNPs with call rates ≤0.95 or
minor allele frequencies of < 0.05. Based on these cri-
teria, all 52 samples and 299,013 SNPs remained for ana-
lysis. The effective number of independent tests (60,027)
was calculated using the genetic type 1 error calculator
(GEC) with default settings [41]. This number was used
to apply a modified Bonferroni significance level (p =
8.33 × 10− 7). To identify loci of interest, data were ana-
lyzed using a chi-squared analysis for basic allelic associ-
ation. An additive Efficient Mixed-Model Association
eXpedited test (EMMAX, F-test) was also performed to
correct for genomic inflation [42]. A visual inspection of
the haplotype from the genome-wide associated regions
was performed and a chi-squared test for independence
comparing the frequency of the identified haplotype in
cases and controls was completed.
hapQTL
To refine the GWAS associated regions, a haplotype
analysis was performed using hapQTL under default
conditions [25]. The analysis was completed on the
SNPs from the GWAS that remained after quality con-
trol. A BF value of 0.0001 was used as the significance
threshold [25].
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Replicating GWAS associations
Thirty-two genome-wide significant SNPs on ECA5,
ECA12 and ECA13 were further evaluated to confirm
associations identified in the GWAS and haplotype ana-
lyses and to replicate findings in additional horses (repli-
cation sample set included 5 additional cases and 37
additional controls). One SNP (ECA5:g.39863319A > G)
was genotyped using a PCR-RFLP analysis (Table S2) as
previously described in Bellone et al. 2017 [34] and the
enzyme BstUI (New England Biolab Inc., Ipswich, MA,
USA) was used to determine genotype based on product
size [43]. The remaining SNPs were genotyped using
Agena MassARRAY spectrometry, which enables the
genotyping of multiple variants simultaneously (Table S3)
[44]. Primers were designed using Typer4.0 for MassAR-
RAY [44] and the iPLEX parameter with high multiplex-
ing was utilized with a modification to the primer-dimer
potential to 0.8. The default parameters were used for the
remaining settings [44]. A Fisher’s exact basic allelic asso-
ciation in SVS was used to compare the allele frequencies
between cases and controls for all replication testing.
Whole genome sequencing
Whole genome sequencing data (Illumina NovaSeq, aver-
age 29X coverage with 150 bp PE reads) from 3 Friesians
affected with distichiasis and 2 unaffected Friesians were
analyzed to identify variants within the ECA13 associated
haplotype for concordance with distichiasis. Reads were
pre-processed and trimmed using HTSstream [45] with
default parameters for all applications except CutTrim,
which was used to remove reads shorter than 50 bp. The
FASTQ files were aligned to EquCab3.0 using the
Burrows-Wheeler Aligner (BWA) [46]. Variants were
called using the default parameters in both FreeBayes and
SAMtools mpileup [47, 48]. Variants identified by both
callers were investigated further. Variant annotation was
performed using SnpEff [49].
Because FOXC2 contains the only known variants to
cause distichiasis in humans, the coding region of horse
FOXC2 (ENSECAG00000000843.2) was also assessed
using the WGS data [13, 14]. This gene maps to ECA3:
g.34103177–34,104,685 in EquCab3.0. The coding re-
gions of the genes present in the 371 kb associated
haplotype region on ECA13 plus 1Mb flanking both the
5′ and 3′ sides of the haplotype were also assessed. Vari-
ants were prioritized for further analysis based on: (1)
perfect concordance with phenotype in the identified
ROH in the samples used for the WGS analysis; and (2)
SnpEff predicted functional effect of high, moderate or
low regardless of concordance with phenotype in the
WGS sample set. These prioritized variants were geno-
typed in a larger cohort of phenotyped Friesian horses
using Agena MassARRAY spectrometry or allele specific
PCR (Table S1). Novel variants were archived in the
European Variation Archive under accession number
PRJEB34362. Primer design was performed as described
above, with a modification to the primer-dimer potential
to 0.7 [44]. Quality control for these data consisted of
the exclusion of samples with call rates ≤0.95, variants
with call rates ≤0.98 or with minor allele frequencies of
< 0.05. Based on these criteria, all 42 samples and 7 vari-
ants remained for analysis. A basic allelic Fisher’s exact
test was completed on this data using SVS.
IGV was utilized to assess alignment and read quality
and identify potential structural variants [50]. LUMPY
[51] was used to confirm visually identified structural
variants.
Sanger sequencing of two cases and two controls
was performed to identify the boundaries of the
ECA13 deletion. Primers and PCR conditions are de-
scribed in Table S4. The addition of 1 μL BSA was
needed to amplify the 3′ end of the deletion. The se-
quences were compared to the EquCab3.0 reference
genome using the NCBI BLAST tool to determine the
precise 5′ and 3′ boundaries of the deletion [52]. The
deletion was also genotyped in a larger cohort of phe-
notyped Friesian horses (n = 90) using a three-primer
allele specific PCR assay (two primers flanking the de-
letion and one internal primer, Table S4). The ampli-
cons were analyzed on an ABI 3730 Genetic Analyzer
and visualized on STRand [53]. A chi-square test for
independence was performed to compare the preva-
lence of the deletion between the cases and the con-
trols. Once the discovery of the deletion was made by
our team, a DNA diagnostic test was developed and it
is now commercially available at the UC Davis Veter-
inary Genetics Laboratory. This commercial assay was
utilized to genotype the deletion in a random sample
of Friesian horses from the Bellone laboratory (n =
201). Additional tests available at the UC Davis Veter-
inary Genetics Laboratory were used to genotype a
subset of the Friesian samples (n = 73) for the hydro-
cephalus and dwarfism mutations. DNA samples from
other horse breeds, banked in the Bellone laboratory,
namely Haflingers (n = 51), Belgian Draft horses (n =
47), Thoroughbreds (n = 95) and Quarter Horses (n =
86) were also genotyped for the ECA13 deletion as de-
scribed above. Of those, all Haflingers and Belgian
Draft horses underwent ocular exams and were deter-
mined to be unaffected by distichiasis. Thoroughbreds
and Quarter Horses were not phenotyped for disti-
chiasis. Mapped equine paired-end WGS BAM files
from the SRA (n = 192) were assessed for the deletion
using LUMPY [51]. Genome STRiP [54] was utilized
to evaluate an additional 95 unmapped paired-end
equine WGS BAM files from the SRA, as well as 389
horse genomes banked in the McCue laboratory.
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Functional investigation
As the deletion identified is located in an intergenic re-
gion, computational analyses were performed to assess
the potential regulatory role of this region as the cause
of distichiasis. The annotated locations of FAM20C,
PDGFA and PRKAR1B from the FAANG RNA-seq data
were visualized using IGV [28, 29]. Publicly available
equine FAANG ChIP-Seq data (H3K4me1, H3K4me,
H3K27ac, and H3K27me3) from eight tissues (adipose,
brain, heart, lamina, liver, lung, ovary, skeletal muscle)
were assessed to investigate potential regulatory regions
[30]. Visualization of regulatory peaks was performed
using IGV.
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